MySugarWatch needle-free continuous glucose monitor for type 2 diabetes on the cards as award-winning Nemaura posts encouraging financials

[Redaktion]

Nemaura, the British company behind the BEAT technology platform for biomarker monitoring, has announced promising financial results. In addition, the firm has also recently won two innovation awards for its work with non-invasive biosensors. The results bode well for MySugarWatch, which aims to give type 2 diabetics an affordable needle-free continuous glucose monitor.

https://www.notebookcheck.net/MySugarWatch-needle-free-continuous-glucose-monitor-for-type-2-diabetes-on-the-cards-as-award-winning-Nemaura-posts-encouraging-financials.605046.0.html

[alalatcnis]

LOL it has been proven that the needle causes heart attacks in 5 countries and many side effects In 20. Stop this tech. it hurts humanity and the world we live in. Imagine having to use this. I am extremely angry at this person who created this tech.

[Yoyoyo5678]

LOL it has been proven that the needle causes heart attacks in 5 countries and many side effects In 20. Stop this tech. it hurts humanity and the world we live in. Imagine having to use this. I am extremely angry at this person who created this tech.

I thought this tech is to replace the needle,   so is it good or not?

[Geetha]

 This technology seems to be a boon to those who are uncomfortable with needle prick.

[Zia Mughal]

It's a good revolutionary innovation of this era requirements. Needle technology was also a latest technology inovation of scientists in that era.  So we should not comment bad on it or its draw backs. There was a lack of features so this new technology is invented or in inovation process with new comfortable features.  Hope for the best!